# APHROZONE USA, INC. – FDA Inspection, Sep 17, 2018

Source: https://www.keypedia.com/records/fda_inspections/aphrozone-usa-inc/79fb4df7-33df-42cb-a9f7-0503bedfb1c8
Source feed: FDA_Inspections

> FDA inspection 1065832 of APHROZONE USA, INC., September 17, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1065832
- Company Name: APHROZONE USA, INC.
- Inspection Date: 2018-09-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/liming-zhang/6c93b721-8725-4d87-8a42-254f3de5e49d)

Company: https://www.keypedia.com/companies/aphrozone-usa-inc/8d4283a8-915d-4828-ad7c-0cae7358a1cd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c